A 12-month phase 3 study of pasireotide in Cushing's disease.

Saved in:
Bibliographic Details
Title: A 12-month phase 3 study of pasireotide in Cushing's disease.
Authors: Colao A (AUTHOR), Petersenn S (AUTHOR), Newell-Price J (AUTHOR), Findling JW (AUTHOR), Gu F (AUTHOR), Maldonado M (AUTHOR), Schoenherr U (AUTHOR), Dipl-Biol (AUTHOR), Mills D (AUTHOR), Salgado LR (AUTHOR), Biller BM (AUTHOR), Pasireotide B2305 Study Group (CORPORATE AUTHOR)
Source: New England Journal of Medicine. 3/8/2012, Vol. 366 Issue 10, p914-924. 11p.
Database: Academic Search Ultimate
Description
ISSN:00284793